Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee J Helman

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Thromboembolic events in children and young adults with pediatric sarcomaIdo Paz-Priel, Lauren Long, Lee J Helman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2012
Gastrointestinal stromal tumor: psychosocial characteristics and considerationsLori Wiener, Haven Battles, Sima Zadeh, et al.
Cancer Genetics and Cytogenetics|June 14, 2005
Telomere stability genes are not mutated in osteosarcoma cell linesSharon A Savage, Brian J Stewart, Jason S Liao, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growthPatrick J Grohar, Laure E Segars, Choh Yeung, et al.
Cancer Research|May 2, 2020
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood RhabdomyosarcomaKatherine K Slemmons, Choh Yeung, Joshua T Baumgart, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumorLarisa V Debelenko, Diane C Arthur, Svetlana D Pack, et al.
Pediatric Blood & Cancer|November 18, 2004
Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experiencePaul C Nathan, Maria Tsokos, Lauren Long, et al.
Cancer Research|October 3, 2008
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibodyLiang Cao, Yunkai Yu, Isaac Darko, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Thromboembolic events in children and young adults with pediatric sarcomaIdo Paz-Priel, Lauren Long, Lee J Helman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2012
Gastrointestinal stromal tumor: psychosocial characteristics and considerationsLori Wiener, Haven Battles, Sima Zadeh, et al.
Cancer Genetics and Cytogenetics|June 14, 2005
Telomere stability genes are not mutated in osteosarcoma cell linesSharon A Savage, Brian J Stewart, Jason S Liao, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growthPatrick J Grohar, Laure E Segars, Choh Yeung, et al.
Cancer Research|May 2, 2020
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood RhabdomyosarcomaKatherine K Slemmons, Choh Yeung, Joshua T Baumgart, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumorLarisa V Debelenko, Diane C Arthur, Svetlana D Pack, et al.
Pediatric Blood & Cancer|November 18, 2004
Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experiencePaul C Nathan, Maria Tsokos, Lauren Long, et al.
Cancer Research|October 3, 2008
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibodyLiang Cao, Yunkai Yu, Isaac Darko, et al.
Pageof 10